Guselkumab effectiveness and survival in patients with psoriasis and psoriatic arthritis: Multicenter analysis in daily clinical practice by the Spanish Psoriasis Group

Overview of attention for article published in Dermatologic Therapy, October 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

blogs: 1 blog
twitter: 3 tweeters

facebook: 1 Facebook page

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 6 Mendeley

Summary Blogs Twitter Facebook Dimensions citations

So far, Dimensions has found 1 citation of this research output.

1

The most recent citing publication is shown below. View this citation on Dimensions.

Effectiveness and Safety of Guselkumab for the Treatment of Psoriasis in Real-World Settings at 52 weeks: A Retrospective, Observational, Multicenter Study from China

Article in Dermatology and Therapy (December 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.